Search Back New search Go to resultsDiseaseMain groupHematological Diseases, Non-MalignantProtocol groupAnemias, CytopeniasDiseaseHbSC diseaseSubgroupICD10D57.2MeSHHemoglobin SC DiseaseSequenceChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceHydroxyureaSupportive substanceHydroxyureaSupportive substanceHydroxyureaSupportive substanceHydroxyureaNo. Substances1Protocol classificationTherapy classificationcurrent standardIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentiondisease controlRisksAnemia Hb below 8g/dlEmetogenicity (ASCO) only studiesPublicationAuthorDei-Adomakoh YADiseaseHbSC-KrankheitOriginUniversity of Ghana Medical School, Accra, GhanaProtocols in Revision 1 protocol foundProtocols under revision.Hydroxyurea 20, HbSC disease (PID2771 V1.0)
